Sr VP Research and Development @ Second Genome (June 2012 - July 2014)
CSO, Senior VP of Research and Development @ Elixir Pharmaceuticals (October 2001 - January 2012)
Consultant @ Cubist Pharmaceuticals (January 2009 - January 2012)
Senior Director of Neurobiology @ (June 1997 - October 2001)
Senior Staff Scientist @ (January 1991 - June 1997)
Senior Cell Biologist @ (December 1986 - January 1991)
Peter Distefano Education
Washington University School of Medicine in St. Louis
Post Doc (Neurobiology)
1983-1986
Upstate Medical University
Doctor of Philosophy (PhD) (Pharmacology)
1980-1983
Kenyon College
Bachelor of Arts (BA) (Biology)
1974-1978
Peter Distefano Skills
Assay Development
Bioinformatics
Biopharmaceuticals
Cancer
Chemistry
Clinical Research
Commercialization
Drug Development
ELISA
Genetics
HPLC
Immunohistochemistry
Medical Devices
Medicinal Chemistry
Protein Chemistry
Proteomics
R&D
Science
Translational Research
Strategy
Customer Service
Molecular Biology
Microsoft Excel
Leadership
Strategic Planning
Data Analysis
Peter Distefano Summary
Peter Distefano, based in Boston, MA, US, is currently a Chief Executive Officer at PJG Pharma LLC. Peter Distefano brings experience from previous roles at Cognesy Therapeutics, Zebra Biologics, Inc., Zebra and Second Genome. Peter Distefano holds a 1983 - 1986 Post Doc in Neurobiology @ Washington University School of Medicine in St. Louis. With a robust skill set that includes Assay Development, Bioinformatics, Biopharmaceuticals, Cancer, Chemistry and more. Peter Distefano has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Peter Distefano?
Find contact details for 700 million professionals.